For: | Duan C, Jenkins ZM, Castle D. Therapeutic use of melatonin in schizophrenia: A systematic review. World J Psychiatr 2021; 11(8): 463-476 [PMID: 34513608 DOI: 10.5498/wjp.v11.i8.463] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v11/i8/463.htm |
Number | Citing Articles |
1 |
Daniel P. Cardinali, Seithikurippu R. Pandi-Perumal, Gregory M. Brown. Sleep and Clocks in Aging and Longevity. Healthy Ageing and Longevity 2023; 18: 277 doi: 10.1007/978-3-031-22468-3_14
|
2 |
Reut Hazani, Michal Lavidor, Aron Weller. Treatments for Social Interaction Impairment in Animal Models of Schizophrenia: A Critical Review and Meta-analysis. Schizophrenia Bulletin 2022; 48(6): 1179 doi: 10.1093/schbul/sbac093
|
3 |
Muhammad Naveed, Owen Y. Chao, Jennifer W. Hill, Yi-Mei Yang, Joseph P. Huston, Ruifeng Cao. Circadian neurogenetics and its implications in neurophysiology, behavior, and chronomedicine. Neuroscience & Biobehavioral Reviews 2024; 157: 105523 doi: 10.1016/j.neubiorev.2023.105523
|
4 |
Eunsoo Moon, Kyungwon Kim, Timo Partonen, Outi Linnaranta. Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness. Current Psychiatry Reports 2022; 24(11): 623 doi: 10.1007/s11920-022-01369-6
|
5 |
K. B. Megha, A. Arathi, Saini Shikha, Rao Alka, Prabhu Ramya, P. V. Mohanan. Significance of Melatonin in the Regulation of Circadian Rhythms and Disease Management. Molecular Neurobiology 2024; 61(8): 5541 doi: 10.1007/s12035-024-03915-0
|
6 |
Ying Zhu, Yuxi Yang, Gongang Ni, Shijin Li, Wei Liu, Zhongbao Gao, Xiao Zhang, Qi Zhang, Changyong Wang, Jin Zhou. On-demand electrically controlled melatonin release from PEDOT/SNP composite improves quality of chronic neural recording. Frontiers in Bioengineering and Biotechnology 2023; 11 doi: 10.3389/fbioe.2023.1284927
|
7 |
Samer El Hayek, Nadine Koukach, Hossameldin Tolba, Wael Foad. Nutrition and Psychiatric Disorders. Nutritional Neurosciences 2024; : 397 doi: 10.1007/978-981-97-2681-3_18
|
8 |
Ahmed Naguy. Therapeutic use of melatonin in schizophrenia-more than meets the eye!. World Journal of Psychiatry 2022; 12(3): 533-535 doi: 10.5498/wjp.v12.i3.533
Abstract(553) |
Core Tip(527) |
Full Article(HTML)(1984)
|
Full Article (PDF)-807K(174)
|
Full Article (Word)-101K(133)
|
Audio-626K(8)
|
Peer-Review Report-225K(69)
|
Answering Reviewers-73K(70)
|
Times Cited (0)
|
Total Visits (5529)
|
Open
|
9 |
Alexandre González-Rodríguez, José Haba-Rubio, Judith Usall, Mentxu Natividad, Virginia Soria, Javier Labad, José A. Monreal. Hormone Targets for the Treatment of Sleep Disorders in Postmenopausal Women with Schizophrenia: A Narrative Review. Clocks & Sleep 2022; 4(1): 52 doi: 10.3390/clockssleep4010007
|
10 |
Rodney R. Dietert, Janice M. Dietert. Using Microbiome-Based Approaches to Deprogram Chronic Disorders and Extend the Healthspan following Adverse Childhood Experiences. Microorganisms 2022; 10(2): 229 doi: 10.3390/microorganisms10020229
|
11 |
Elise Koch, Karolina Kauppi, Chi-Hua Chen. Candidates for drug repurposing to address the cognitive symptoms in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2023; 120: 110637 doi: 10.1016/j.pnpbp.2022.110637
|
12 |
Yaiza Potes, Cristina Cachán-Vega, Eduardo Antuña, Claudia García-González, Nerea Menéndez-Coto, Jose Antonio Boga, José Gutiérrez-Rodríguez, Manuel Bermúdez, Verónica Sierra, Ignacio Vega-Naredo, Ana Coto-Montes, Beatriz Caballero. Benefits of the Neurogenic Potential of Melatonin for Treating Neurological and Neuropsychiatric Disorders. International Journal of Molecular Sciences 2023; 24(5): 4803 doi: 10.3390/ijms24054803
|
13 |
Jitendra Kumar Sinha, Punya Sachdeva, Faizan Ahmad, Jasmine Sarkar, Raafiah Izhar, Ayesha Rahman, Shampa Ghosh. Cognizance of Schizophrenia:: A Profound Insight into the Psyche. 2023; : 149 doi: 10.1007/978-981-19-7022-1_10
|
14 |
Tsutomu Takahashi, Stephen J. Wood, Alison R. Yung, Barnaby Nelson, Ashleigh Lin, Hok Pan Yuen, Lisa J. Phillips, Michio Suzuki, Patrick D. McGorry, Dennis Velakoulis, Christos Pantelis. Pineal morphology of the clinical high-risk state for psychosis and different psychotic disorders. Schizophrenia Research 2022; 244: 1 doi: 10.1016/j.schres.2022.04.005
|
15 |
Namra Aziz, Vipin Kumar Garg, Yadav Rupali Vinod, Arpit Gupta, Ankita Wal, Shruti Rathore, Pranay Wal. An Update on the Role of Circadian Rhythms in Sleep Disorders. Current Drug Therapy 2024; 19(3): 302 doi: 10.2174/1574885518666230818102714
|
16 |
Zanjbeel Mahmood, Arren Ramsey, Neha Kidambi, Alexa Hernandez, Hayden Palmer, Jinyuan Liu, Xin M. Tu, Sonia Ancoli-Israel, Atul Malhotra, Stephen Smagula, Ellen E. Lee. Rest-activity rhythm disruption and metabolic health in schizophrenia: a cross-sectional actigraphy study of community-dwelling people living with schizophrenia and nonpsychiatric comparison participants. Journal of Clinical Sleep Medicine 2024; 20(9): 1505 doi: 10.5664/jcsm.11192
|
17 |
Abdolhakim Ghanbarzehi, Ali Sepehrinezhad, Nazanin Hashemi, Minoo Karimi, Ali Shahbazi. Disclosing common biological signatures and predicting new therapeutic targets in schizophrenia and obsessive–compulsive disorder by integrated bioinformatics analysis. BMC Psychiatry 2023; 23(1) doi: 10.1186/s12888-023-04543-z
|
18 |
Mahdi Rafiyian, Russel J. Reiter, Sayyed Mehdi Rasooli Manesh, Reza Asemi, Mehran Sharifi, Sotoudeh Mohammadi, Mohammad Ali Mansournia, Zatollah Asemi. Programmed cell death and melatonin: A comprehensive review. Functional & Integrative Genomics 2024; 24(5) doi: 10.1007/s10142-024-01454-4
|
19 |
Shen-Chieh Chang, Kah Kheng Goh, Mong-Liang Lu. Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives. World Journal of Psychiatry 2021; 11(10): 696-710 doi: 10.5498/wjp.v11.i10.696
|
20 |
Satyam Chauhan, Andrei Barbanta, Ulrich Ettinger, Veena Kumari. Pineal Abnormalities in Psychosis and Mood Disorders: A Systematic Review. Brain Sciences 2023; 13(5): 827 doi: 10.3390/brainsci13050827
|